Published in Gut on May 01, 1981
Pyoderma gangrenosum after cholecystectomy. Br Med J (Clin Res Ed) (1986) 1.29
Erythema nodosum progressing to pyoderma gangrenosum as a complication of Crohn's disease. Postgrad Med J (1983) 0.84
Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease. Dig Dis Sci (2006) 0.80
Association between pyoderma gangrenosum and ulcerative colitis. J R Soc Med (1992) 0.75
Pyoderma gangrenosum: A case report of bilateral dorsal hand lesions and literature review of management. Can J Plast Surg (2013) 0.75
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Circulating immune complexes in inflammatory bowel disease. Clin Exp Immunol (1973) 4.32
Capillary resistance and adrenocortical activity. Br Med J (1950) 3.53
Pyoderma gangrenosum and ulcerative colitis. Gut (1980) 1.24
The hemostatic defect in thrombocytopenia as studied by the use of ACTH and cortisone. Am J Med (1952) 1.21
Inflammatory bowel disease associated circulating immune complexes. Gut (1980) 1.19
Relationship of erythema nodosum to other manifestations of Crohn's disease. Cleve Clin Q (1977) 0.90
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry (2000) 2.19
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Perpetuation of published medical errors. Lancet (1993) 1.43
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Granulomatous ileocolitis. Gut (1966) 1.42
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Aging and mental health: primary care of the healthy older adult. A roundtable discussion: Part I. Geriatrics (1992) 1.37
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Recurrent regional ileitis after ileostomy and colectomy for granulomatous colitis. N Engl J Med (1972) 1.33
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Influence of glucagon on pancreatic exocrine secretion. Gastroenterology (1969) 1.12
Secretion of calcium by the canine pancreas. Gastroenterology (1967) 1.10
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon? Am J Gastroenterol (1974) 1.06
Mucosal blood flow in canine antral and fundic pouches. Gastroenterology (1971) 1.04
Lymphoma in inflammatory bowel disease. Cancer (1992) 1.03
Effect of secretin and acetazolamide on the volume and electrolyte composition of hepatic bile in man. Gastroenterology (1969) 1.02
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01
Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol (1987) 1.00
Quality of life after surgery for Crohn's disease: a psychosocial survey. Gastroenterology (1980) 0.99
A family with collagenous colitis, ulcerative colitis, and Crohn's disease. Am J Gastroenterol (2000) 0.98
Subdiaphragmatic bronchogenic cyst with gastric communication. Gastrointest Radiol (1988) 0.97
Secretory capacity of stomach and pancreas in man. Gastroenterology (1967) 0.97
Adenocarcinoma in strictures of ulcerative colitis without antecedent dysplasia by colonoscopy. Am J Gastroenterol (1994) 0.95
Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial. J Clin Gastroenterol (1990) 0.95
Intraabdominal abscess in Crohn's (ileo) colitis. Am J Surg (1982) 0.95
"Natural history" of Crohn's disease. An analytic review of the placebo lesson. Gastroenterology (1984) 0.94
Effects of prostaglandin E1 on pancreatic exocrine function. Gastroenterology (1971) 0.94
Autoimmune hemolytic anemia in ulcerative colitis: report of three cases, review of the literature, and evaluation of modes of therapy. Dig Dis Sci (1979) 0.92
Cancer in universal and left-sided ulcerative colitis: clinical and pathologic features. Mt Sinai J Med (1979) 0.92
Effect of glucagon on hepatic bile secretion in man. Gastroenterology (1971) 0.92
Folic acid and hexose absorption in sprue. Am J Dig Dis (1974) 0.91
Influence of histoincompatibility between mother and foetus on placental size in mice. Nature (1971) 0.90
The pancreas. Gastroenterology (1966) 0.90
Bile in the stomach. Gastroenterology (1969) 0.90
How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol (1995) 0.90
Acute myelogenous leukemia in patients with ulcerative colitis. J Clin Gastroenterol (1980) 0.89
Some metabolic aspects of exocrine pancreatic disease. Gastroenterology (1969) 0.89
Circulating carcinoembryonic antigen (CEA): relationship to clinical status of patients with inflammatory bowel disease. Gut (1973) 0.89
Fulminant herpes simplex hepatitis in a patient with ulcerative colitis. Gut (1988) 0.88
Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology (1988) 0.88
Rectourethroperineal fistula in Crohn's disease. Am J Gastroenterol (1985) 0.88
Alterations in serum immunoglobulins after resection for ulcerative and granulomatous disease of the intestine. Gut (1972) 0.87
Toxic megacolon in ulcerative colitis complicated by pneumomediastinum: report of two cases. Gastroenterology (1980) 0.87
Controversy on recurrent ileitis after ileostomy: background and speculation. Gastroenterology (1973) 0.87
Carcinoma of the ileum 25 years after bypass for regional enteritis. A case report. Mt Sinai J Med (1971) 0.87
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol (1993) 0.87
The effect of bile on electrolyte movement across canine gastric antral and fundic mucosa. Gastroenterology (1970) 0.86
Systemic amyloidosis and the gastrointestinal tract. Gastroenterol Clin North Am (1998) 0.86
Mycobacterium avium-intracellulare-associated colitis in a patient with the acquired immunodeficiency syndrome. J Clin Gastroenterol (1984) 0.86
Crohn's disease--50 years later. N Engl J Med (1981) 0.85
Electrolyte movement across canine antral and fundic gastric mucosa. Gastroenterology (1969) 0.85
[How to calculate the natural history of a disease]. Gastroenterol Clin Biol (1979) 0.85
Granulomatous colitis in association with diverticula. N Engl J Med (1970) 0.85
Inhibitory effect of ethanol on canine exocrine pancreatic secretion. Gastroenterology (1972) 0.84
Pentagastrin infusion-glycine instillation as a measure of acid absorption in the human stomach: comparison to an instilled acid load. Gastroenterology (1972) 0.84
Editorial: A transmissible agent in Crohn's disease? New pursuit of an old concept. N Engl J Med (1975) 0.84
Effect of acetazolamide and cholecystokinin on the secretion of pepsin from histamine-stimulated Heidenhain pouches. Gastroenterology (1967) 0.83
Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology (1983) 0.83
The effect of alloxan upon canine exocrine pancreatic secretion. Am J Gastroenterol (1968) 0.82
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studies. Gut (1978) 0.81
Effects of some inhibitors of sodium transport (adenosine triphosphatase inhibitors) on pancreatic secretion. Gastroenterology (1972) 0.81
Problems in Crohn's disease: evaluation of the results of surgical treatments. J Chronic Dis (1975) 0.81
Olsalazine in the treatment of ulcerative colitis among patients intolerant of sulphasalazine: a prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Scand J Gastroenterol Suppl (1988) 0.81
The "natural history" of ulcerative colitis: an analysis of the placebo response. J Clin Gastroenterol (1989) 0.81
Granulomatous gastritis: a case report and review of the literature. Am J Gastroenterol (1989) 0.80
Parasympathetic innervation and pancreatic secretion: the role of the gastric antrum. Ann Surg (1976) 0.80
Secretion of sodium by the resting, stimulated, and inhibited canine gastric mucosa. Am J Physiol (1967) 0.80
Does intestinal resection heal the pyoderma gangrenosum of inflammatory bowel disease? J Clin Gastroenterol (1983) 0.80
Cancer in Crohn's disease. The danger of a by-passed loop. Am J Gastroenterol (1975) 0.80
Loss of suppressor T-cells in active inflammatory bowel disease. Gut (1984) 0.80
Left-handedness and inflammatory bowel disease. J Clin Gastroenterol (1985) 0.80
Folic acid absorption in man: enhancing effect of glucose. Gastroenterology (1971) 0.80
Small intestinal absorptive function in regional enteritis. Gastroenterology (1973) 0.79
[Effect of d-1-ethionine on electrolyte secretion of the dog pancreas]. Am J Physiol (1963) 0.79